Where does Ziemer Ophthalmic Systems AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ziemer Ophthalmic Systems AG ranks #8,520 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ziemer Ophthalmic Systems AG hold?

Ziemer Ophthalmic Systems AG holds 38 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is Ziemer Ophthalmic Systems AG's Innovation Score?

Ziemer Ophthalmic Systems AG has an Innovation Score of 38.2 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Ziemer Ophthalmic Systems AG's patent grant rate increasing or decreasing?

Ziemer Ophthalmic Systems AG's recent grant velocity is +213% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Ziemer Ophthalmic Systems AG's patents?

Ziemer Ophthalmic Systems AG's patents average 16.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Ziemer Ophthalmic Systems AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ziemer Ophthalmic Systems AG

Q: What technology areas does Ziemer Ophthalmic Systems AG focus on?

Ziemer Ophthalmic Systems AG's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 38 patents, ranking #165 of 3,082 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 38 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ziemer ranks #8,520 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 8 technology areas.

#8,520
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.2/100): 16.9
avg claims per patent: +213%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8520 · Foreign Corporation #8,520 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 38 grants
UPPER-Q #8,520/49,997
PHOTO-FINISH Xevo
CPC-NARROW A61F · 8 areas
INNOV-THIN 38.2/100
CLAIMS-RICH 16.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +213% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Xevo Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ziemer’s 38.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.7 pts (33%) Velocity 5.4 pts (14%) Breadth 10.0 pts (26%) Claim depth 10.2 pts (27%)

Qualcomm Incorporated · highest

85
American Internation… · near

38
Cyberlink · near

38
Honey BEE Manufactur… · near

38
Legrand AV · near

38
Ziemer Ophthalmic… · this assignee

38
3D Lighting… · lowest

7

What this shows Ziemer's Innovation Score is 38.2/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ziemer?

Each dot is one of Ziemer’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ziemer’s own 16.9 claims/patent is ABOVE the 15.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ziemer vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ziemer's grants concentrate

Ziemer Ophthalmic Systems AG is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (7 grants) versus a trough of 1 in 2015. By volume, Ziemer sits between Xevo Inc. and Allnex Austria GMBH.

Ziemer's three-year grant acceleration

Ziemer Ophthalmic Systems AG shows 13 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Xevo

38
Yext

38
Yieldmo

38
Zhejiang Dunan Ar…

38
Ziemer Ophthalmic… ◀

38
7rdd

37
ABS Global

37
ABT

37
Allnex Austria

37

What this shows Ziemer holds 38 patents at rank #8,520, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ziemer

By rank, the assignees closest to #8,520 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Ziemer's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ziemer, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Ziemer ranks #165 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

American International Group, Inc. 38 Legrand AV Inc. 38 Honey BEE Manufacturing Ltd. 38 Cyberlink Corp. 38

Ziemer's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Ziemer Ophthalmic Systems AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	2.6%
2016	1	2.6%
2017	2	5.3%
2019	4	10.5%
2020	7	18.4%
2021	5	13.2%
2022	4	10.5%
2023	6	15.8%
2024	3	7.9%
2025partial year	5	13.2%

Which technologies does Ziemer Ophthalmic Systems AG patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 38

A61B - DIAGNOSIS; SURGERY; Identification 12

G06T - Image Data Processing OR Generation, IN General 2

G01M - Testing Static OR Dynamic Balance OF Machines OR STRUCTURES; Testing OF Structures OR Apparatus, NOT Otherwise Provided FOR 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

B23K - Soldering OR UNSOLDERING; WELDING; Cladding OR Plating BY Soldering OR WELDING; Cutting BY Applying Heat Locally, e.g. Flame CUTTING; Working BY Laser Beam 1

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ziemer Ophthalmic Systems AG's patent record in context - here's where to go next.

Ziemer Ophthalmic Systems AG's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #8,520 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ziemer Ophthalmic Systems AG against Xevo Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.